Heidelberg Pharma AG (FRA:HPHA)
2.840
+0.010 (0.35%)
At close: Dec 4, 2025
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 105 employees as of November 30, 2024. The number of employees increased by 10 or 10.53% compared to the previous year.
Employees
105
Change (1Y)
10
Growth (1Y)
10.53%
Revenue / Employee
€26,644
Profits / Employee
€229,629
Market Cap
132.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Heidelberg Pharma AG News
- 4 weeks ago - EQS-News: Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma - Wallstreet:Online
- 4 weeks ago - EQS-News: Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar - Wallstreet:Online
- 7 weeks ago - EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 2 months ago - Heidelberg Pharma's Bold Moves in 2025's First 9 Months - Wallstreet:Online
- 2 months ago - EQS-News: Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025 - Wallstreet:Online
- 2 months ago - Heidelberg Pharma AG Boosts Outlook: Exciting New Guidance Revealed! - Wallstreet:Online
- 2 months ago - EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance - Wallstreet:Online
- 2 months ago - EQS-News: Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma - Wallstreet:Online